Literature DB >> 11263793

Mortality from coronary heart disease and acute myocardial infarction--United States, 1998.

.   

Abstract

Despite improved clinical care, heightened public awareness, and widespread use of health innovations, coronary heart disease (CHD) remains the leading cause of death in the United States, and the decline in rates from CHD that began during the 1960s slowed during the 1990s. This report provides national and state-specific death rates for CHD and for acute myocardial infarction (AMI). During 2001, approximately 1.1 million persons are expected to have a CHD event. Prevention remains the key strategy for reducing CHD mortality.

Entities:  

Mesh:

Year:  2001        PMID: 11263793

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  10 in total

1.  Common variants of large effect in F12, KNG1, and HRG are associated with activated partial thromboplastin time.

Authors:  Lorna M Houlihan; Gail Davies; Albert Tenesa; Sarah E Harris; Michelle Luciano; Alan J Gow; Kevin A McGhee; David C Liewald; David J Porteous; John M Starr; Gordon D Lowe; Peter M Visscher; Ian J Deary
Journal:  Am J Hum Genet       Date:  2010-03-18       Impact factor: 11.025

2.  Clean indoor air laws immediately reduce heart attacks.

Authors:  Alexis Dinno; Stanton Glantz
Journal:  Prev Med       Date:  2007-04-14       Impact factor: 4.018

3.  Acute myocardial infarction in New York State: 1996-2008.

Authors:  Harold Kilburn; Lawrence Schoen; Tong Wang
Journal:  J Community Health       Date:  2012-04

Review 4.  Innovative approaches to comprehensive cardiovascular disease risk reduction in clinical and community-based settings.

Authors:  N F Gordon; R D Salmon; B S Mitchell; G C Faircloth; L I Levinrad; S Salmon; W E Saxon; K S Reid
Journal:  Curr Atheroscler Rep       Date:  2001-11       Impact factor: 5.113

5.  Diagnostic value of routine clinical parameters in acute myocardial infarction: a comparison to delayed contrast enhanced magnetic resonance imaging. Delayed enhancement and routine clinical parameters after myocardial infarction.

Authors:  Steffen E Petersen; Georg Horstick; Thomas Voigtländer; Karl-Friedrich Kreitner; Thomas Wittlinger; Steffen Ziegler; Nico Abegunewardene; Melanie Schmitt; Wolfgang G Schreiber; Peter Kalden; Oliver K Mohrs; Manfred Thelen; Juergen Meyer
Journal:  Int J Cardiovasc Imaging       Date:  2003-10       Impact factor: 2.357

6.  Glycine reduces platelet aggregation.

Authors:  Peter Schemmer; Zhi Zhong; Uwe Galli; Michael D Wheeler; Li Xiangli; Blair U Bradford; Lars O Conzelmann; Dow Forman; José Boyer; Ronald G Thurman
Journal:  Amino Acids       Date:  2012-11-08       Impact factor: 3.520

7.  Does interhospital transfer improve outcome of acute myocardial infarction? A propensity score analysis from the Cardiovascular Cooperative Project.

Authors:  John M Westfall; Catarina I Kiefe; Norman W Weissman; Anthony Goudie; Robert M Centor; O Dale Williams; Jeroan J Allison
Journal:  BMC Cardiovasc Disord       Date:  2008-09-09       Impact factor: 2.298

8.  The tell-tale heart: population-based surveillance reveals an association of rofecoxib and celecoxib with myocardial infarction.

Authors:  John S Brownstein; Margarita Sordo; Isaac S Kohane; Kenneth D Mandl
Journal:  PLoS One       Date:  2007-09-05       Impact factor: 3.240

9.  Antihyperlipidemic effects of Citrus sinensis, Citrus paradisi, and their combinations.

Authors:  Neelam Mallick; Rafeeq Alam Khan
Journal:  J Pharm Bioallied Sci       Date:  2016 Apr-Jun

10.  Racial/ethnic disparities among Asian Americans in inpatient acute myocardial infarction mortality in the United States.

Authors:  Eun Ji Kim; Nancy R Kressin; Michael K Paasche-Orlow; Lenny Lopez; Jennifer E Rosen; Mengyun Lin; Amresh D Hanchate
Journal:  BMC Health Serv Res       Date:  2018-05-16       Impact factor: 2.655

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.